Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Critically ill patients in the intensive care unit often receive continuous hemodialysis to
treat their kidney failure. Ertapenem is an antibiotic often used in these patients.
Continuous dialysis may remove ertapenem, putting patients at risk for inappropriate
treatment of their infection. This study will determine how much ertapenem is removed by
continuous hemodialysis.